Recent Successes 2004 Archive
Cytomedix Obtains Favorable Markman Claim Interpretation Ruling
March 26, 2004
Fitch Even client, Cytomedix, Inc., has received a favorable ruling from U.S. District Court Judge James B. Zagel of the Northern District of Illinois regarding the scope of the claims of U.S. Patent No. 5,165,938. The patent relates to the use of platelet-derived therapies for treating wounds and other damaged tissue. Judge Zagel's ruling represents a significant milestone for Cytomedix in its ongoing efforts to enforce the patent in the company's core chronic wound care market, as well as within a number of other markets where platelet gel therapies are currently utilized to enhance the quality of healing.
Fitch Even's litigation team for Cytomedix includes John Flannery, Tim Maloney, Karl Fink and Rudy Kratz.
